Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
NYS Entity Status
NYS Filing Date
APRIL 09, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2014 - BRODCOM WEST DEVELOPMENT COMPANY LLC
AROUND THE WEB
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
- Surprise Kanye West Show Sparks Chaos in NYC
Monday Jun 6, 2016
A surprise Kanye West show sparked chaos outside New York City’s Webster Hall early Monday as more than 4,000 fans descended on the venue. The show was later canceled. Photo: AP.
- Charter Urges Judge To Throw Out NY's Suit Over Slow Web Connections
Tuesday Jun 20, 2017
Cable company Charter is asking a judge to dismiss a lawsuit by New York Attorney General Eric Schneiderman, who alleges that the company duped consumers by delivering slower-than-advertised broadbandspeeds.
- Five Sites of New York’s L.G.B.T. History
Monday Jun 19, 2017
Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
- New York City and James Blake Resolve Excessive-Force Claim
By BENJAMIN MUELLER - Wednesday Jun 21, 2017
As part of the deal with the former pro tennis player, the city will create a new position within the agency that investigates police misconduct.
- Ask the NY Giants: Socks with Sandals?
Tuesday Sep 15, 2015
Professional athletes like members of the New York Giants are the inspiration for the latest (counterintuitive) high-fashion trend: wearing socks with sandals. Photo: Stu Woo/The Wall Street Journal
- Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
By Frank Vinluan - Wednesday Jun 14, 2017
The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]